{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:32:23Z","timestamp":1792017143491,"version":"4.4.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejpb.2024.114474","type":"journal-article","created":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T01:35:42Z","timestamp":1724549742000},"page":"114474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Hyaluronidase overcomes the extracellular matrix barrier to enhance local drug delivery"],"prefix":"10.1016","volume":"203","author":[{"given":"Jingru","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0609-5376","authenticated-orcid":false,"given":"Xiaoqing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114474_b0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.addr.2018.12.006","article-title":"Advances in transdermal insulin delivery","volume":"139","author":"Zhang","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2024.114474_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173691","article-title":"Nanocarriers for treatment of dermatological diseases: principle, perspective and practices","volume":"890","author":"Ramanunny","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114474_b0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1515\/bmt-2019-0019","article-title":"Non-invasive drug delivery technology: development and current status of transdermal drug delivery devices, techniques and biomedical applications","volume":"65","author":"Akhtar","year":"2020","journal-title":"Biomed Eng-Biomed Te"},{"key":"10.1016\/j.ejpb.2024.114474_b0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.addr.2017.08.009","article-title":"Device-assisted transdermal drug delivery","volume":"127","author":"Lee","year":"2018","journal-title":"Adv. Drug. Del. Rev."},{"issue":"20","key":"10.1016\/j.ejpb.2024.114474_b0025","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.2174\/1381612821666150428145216","article-title":"Nanocarriers and their actions to improve skin permeability and transdermal drug delivery","volume":"21","author":"Khan","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114474_b0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/17425247.2020.1713087","article-title":"Permeation enhancers in transdermal drug delivery: benefits and limitations","volume":"17","author":"Kovacik","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114474_b0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jddst.2016.09.009","article-title":"Enhancing percutaneous permeability of sinomenine hydrochloride using dual-frequency sonophoresis","volume":"36","author":"Yin","year":"2016","journal-title":"J Drug Deliv Sci Tec"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114474_b0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jconrel.2010.08.015","article-title":"Magnetophoresis for enhancing transdermal drug delivery: mechanistic studies and patch design","volume":"148","author":"Murthy","year":"2010","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114474_b0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2011.07.024","article-title":"Erbium: YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies","volume":"156","author":"Yu","year":"2011","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114474_b0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jconrel.2011.05.003","article-title":"Microsecond thermal ablation of skin for transdermal drug delivery","volume":"154","author":"Lee","year":"2011","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.ejpb.2024.114474_b0055","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3109\/03639041003786193","article-title":"Electroporation of polymeric nanoparticles: an alternative technique for transdermal delivery of insulin","volume":"36","author":"Rastogi","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2024.114474_b0060","article-title":"Overview of recent advancements in the iontophoretic drug delivery to various tissues and organs","volume":"61","author":"Helmy","year":"2021","journal-title":"J Drug Deliv Sci Tec"},{"key":"10.1016\/j.ejpb.2024.114474_b0065","article-title":"Photoreactive-proton-generating hyaluronidase\/albumin nanoparticles-loaded PEG-hydrogel enhances antitumor efficacy and disruption of the hyaluronic acid extracellular matrix in AsPC-1 tumors","volume":"12","author":"Lee","year":"2021","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.ejpb.2024.114474_b0070","doi-asserted-by":"crossref","first-page":"eaao0475","DOI":"10.1126\/scitranslmed.aao0475","article-title":"Targeting extracellular matrix stiffness to attenuate disease: from molecular mechanisms to clinical trials","volume":"10","author":"Lampi","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejpb.2024.114474_b0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","article-title":"Extracellular matrix structure","volume":"97","author":"Theocharis","year":"2016","journal-title":"Adv Drug Deliver Rev"},{"key":"10.1016\/j.ejpb.2024.114474_b0080","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.2147\/IJN.S257164","article-title":"Mechanism investigation of hyaluronidase-combined multistage nanoparticles for solid tumor penetration and antitumor effect","volume":"15","author":"Chen","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2024.114474_b0085","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.3390\/ijms23158418","article-title":"Targeting fibronectin to overcome remyelination failure in multiple sclerosis: the need for brain- and lesion-targeted drug delivery","volume":"23, (15)","author":"van Schaik","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2024.114474_b0090","doi-asserted-by":"crossref","first-page":"tkac040","DOI":"10.1093\/burnst\/tkac040","article-title":"CO2 fractional laser-assisted transdermal delivery of silk nanofiber carriers in a rabbit ear hypertrophic scar model","volume":"10","author":"Yang","year":"2022","journal-title":"Burns Trauma"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114474_b0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41573-019-0040-5","article-title":"Targeting metabolic dysregulation for fibrosis therapy","volume":"19","author":"Zhao","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejpb.2024.114474_b0100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jconrel.2023.05.002","article-title":"Delivery of hydroxycamptothecin via sonoporation: an effective therapy for liver fibrosis","volume":"358","author":"Chen","year":"2023","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114474_b0105","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1080\/14756366.2021.1960830","article-title":"Cyanobacteria and microalgae bioactive compounds in skin-ageing: potential to restore extracellular matrix filling and overcome hyperpigmentation","volume":"36","author":"Favas","year":"2021","journal-title":"J Enzym Inhib Med Ch"},{"key":"10.1016\/j.ejpb.2024.114474_b0110","doi-asserted-by":"crossref","first-page":"e2202156","DOI":"10.1002\/smll.202202156","article-title":"Injectable double positively charged hydrogel microspheres for targeting-penetration-phagocytosis","volume":"18","author":"Lin","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2024.114474_b0115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2017.02.035","article-title":"Extracellular matrix remodeling in vivo for enhancing tumor-targeting efficiency of nanoparticle drug carriers using the pulsed high intensity focused ultrasound","volume":"263","author":"Lee","year":"2017","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114474_b0120","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.7150\/thno.51383","article-title":"Targeting transforming growth factor-\u03b2 signaling for enhanced cancer chemotherapy","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"issue":"30","key":"10.1016\/j.ejpb.2024.114474_b0125","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1002\/anie.201201902","article-title":"Acoustic droplet vaporization and propulsion of perfluorocarbon-loaded microbullets for targeted tissue penetration and deformation","volume":"51","author":"Kagan","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"issue":"17","key":"10.1016\/j.ejpb.2024.114474_b0130","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1200\/JCO.2012.46.3653","article-title":"Normalizing Tumor microenvironment to treat cancer: bench to bedside to biomarkers","volume":"31","author":"Jain","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2024.114474_b0135","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jconrel.2022.11.046","article-title":"Hyaluronidase-powered microneedles for significantly enhanced transdermal delivery efficiency","volume":"353","author":"Hu","year":"2023","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.ejpb.2024.114474_b0140","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/1090820X13511970","article-title":"The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers","volume":"33","author":"Cavallini","year":"2013","journal-title":"Aesthet. Surg. J."},{"key":"10.1016\/j.ejpb.2024.114474_b0145","first-page":"V-Vi","article-title":"Therapeutic enzymes: function and clinical implications preface","volume":"1148","author":"Labrou","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114474_b0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/srt.12968","article-title":"Methods for evaluating penetration of drug into the skin: a review","volume":"27","author":"Supe","year":"2021","journal-title":"Skin Res. Technol."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114474_b0155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/imm.13152","article-title":"Skin barrier immunity and ageing","volume":"160","author":"Chambers","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.ejpb.2024.114474_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116364","article-title":"Hyaluronic acid-Based wound dressings: a review","volume":"241","author":"Gra\u00e7a","year":"2020","journal-title":"Carbohyd Polym"},{"key":"10.1016\/j.ejpb.2024.114474_b0165","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3389\/fphar.2020.01105","article-title":"Hyaluronic acid-mediated drug delivery system targeting for inflammatory skin diseases: a mini review","volume":"11","author":"How","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2024.114474_b0170","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.3390\/cells10113096","article-title":"Epidermal hyaluronan in barrier alteration-related disease","volume":"10, (11)","author":"Evrard","year":"2021","journal-title":"Cells-Basel"},{"key":"10.1016\/j.ejpb.2024.114474_b0175","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/brain\/awab059","article-title":"The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis","volume":"144","author":"Ghorbani","year":"2021","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.ejpb.2024.114474_b0180","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrm3902","article-title":"Extracellular matrix assembly: a multiscale deconstruction","volume":"15","author":"Mouw","year":"2014","journal-title":"Nat Rev Mol Cell Bio"},{"key":"10.1016\/j.ejpb.2024.114474_b0185","doi-asserted-by":"crossref","first-page":"e1503","DOI":"10.1002\/wnan.1503","article-title":"Extracellular matrix remodeling in 3D: implications in tissue homeostasis and disease progression","volume":"10, (4)","author":"Ford","year":"2018","journal-title":"Wires Nanomed Nanobi"},{"key":"10.1016\/j.ejpb.2024.114474_b0190","article-title":"An Overview of Extracellular Matrix-Based Bioinks for 3D Bioprinting","volume":"10","author":"Wang","year":"2022","journal-title":"Front Bioeng Biotech"},{"key":"10.1016\/j.ejpb.2024.114474_b0195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcis.2018.04.084","article-title":"Hybrid pH-sensitive nanogels surface-functionalized with collagenase for enhanced tumor penetration","volume":"525","author":"Wang","year":"2018","journal-title":"J Colloid Interf Sci"},{"issue":"50","key":"10.1016\/j.ejpb.2024.114474_b0200","doi-asserted-by":"crossref","first-page":"43493","DOI":"10.1021\/acsami.8b17684","article-title":"Collagenase-encapsulated ph-responsive nanoscale coordination polymers for tumor microenvironment modulation and enhanced photodynamic nanomedicine","volume":"10","author":"Liu","year":"2018","journal-title":"Acs Appl Mater Inter"},{"issue":"25","key":"10.1016\/j.ejpb.2024.114474_b0205","doi-asserted-by":"crossref","first-page":"12524","DOI":"10.1039\/C5NR08463F","article-title":"Improving nanoparticle diffusion through tumor collagen matrix by photo-thermal gold nanorods","volume":"8","author":"Raeesi","year":"2016","journal-title":"Nanoscale"},{"issue":"27","key":"10.1016\/j.ejpb.2024.114474_b0210","doi-asserted-by":"crossref","first-page":"22985","DOI":"10.1021\/acsami.8b07090","article-title":"Synergizing upconversion nanophotosensitizers with hyperbaric oxygen to remodel the extracellular matrix for enhanced photodynamic cancer therapy","volume":"10","author":"Li","year":"2018","journal-title":"Acs Appl Mater Inter"},{"key":"10.1016\/j.ejpb.2024.114474_b0215","unstructured":"United States Food and Drug Administration. Marketing Clearance of Diagnostic Ultrasound Systems and Transducers. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/marketing-clearance-diagnostic-ultrasound-systems-and-transducers."},{"key":"10.1016\/j.ejpb.2024.114474_b0220","doi-asserted-by":"crossref","first-page":"2295232","DOI":"10.1080\/02656736.2023.2295232","article-title":"Factors associated with thermal injury of abdominal skin in focused ultrasound ablation of uterine fibroids","volume":"41","author":"Chendian","year":"2024","journal-title":"Int J Hyperther"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114474_b0225","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/srt.12347","article-title":"High-intensity focused ultrasound treatment for skin: evaluation","volume":"23","author":"Park","year":"2017","journal-title":"Skin Res. Technol."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114474_b0230","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/srt.12661","article-title":"High-frequency (20-MHz) high-intensity focused ultrasound (HIFU) system for dermal intervention: Preclinical evaluation in skin equivalents","volume":"25","author":"Bove","year":"2019","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.ejpb.2024.114474_b0235","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addr.2021.02.019","article-title":"Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma q","volume":"172","author":"Liu","year":"2021","journal-title":"Adv Drug Deliver Rev"},{"key":"10.1016\/j.ejpb.2024.114474_b0240","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2014.05.019","article-title":"Improving the distribution of Doxil\u00ae in the tumor matrix by depletion of tumor hyaluronan","volume":"191","author":"Kohli","year":"2014","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.ejpb.2024.114474_b0245","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/0008-5472.CAN-14-1027","article-title":"Chaperone Hsp47 drives malignant growth and invasion by modulating an ECM gene network","volume":"75","author":"Zhu","year":"2015","journal-title":"Cancer Res."},{"issue":"41","key":"10.1016\/j.ejpb.2024.114474_b0250","doi-asserted-by":"crossref","first-page":"16618","DOI":"10.1073\/pnas.1117610109","article-title":"TGF-\u03b2 blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma","volume":"109","author":"Liu","year":"2012","journal-title":"P Natl Acad Sci USA"},{"issue":"20","key":"10.1016\/j.ejpb.2024.114474_b0255","first-page":"3968","article-title":"Property and current clinical applications of mammal hyaluronidase","volume":"19","author":"Lv","year":"2015","journal-title":"Eur Rev Med Pharmaco"},{"key":"10.1016\/j.ejpb.2024.114474_b0260","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40001-016-0201-5","article-title":"Hyaluronidase: from clinical applications to molecular and cellular mechanisms","volume":"21","author":"Buhren","year":"2016","journal-title":"Eur. J. Med. Res."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114474_b0265","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5999\/aps.2020.00752","article-title":"Hyaluronidase: An overview of its properties, applications, and side effects","volume":"47","author":"Jung","year":"2020","journal-title":"Arch Plast Surg-Aps"},{"key":"10.1016\/j.ejpb.2024.114474_b0270","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-981-13-7709-9_12","article-title":"Clinical applications of hyaluronidase","volume":"1148","author":"Weber","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114474_b0275","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000360545","article-title":"Use of hyaluronidase for pharmacokinetic increase in bioavailability of intracutaneously applied substances","volume":"27","author":"Wohlrab","year":"2014","journal-title":"Skin Pharmacol. Physiol."},{"issue":"12","key":"10.1016\/j.ejpb.2024.114474_b0280","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2217\/imt-2017-0092","article-title":"Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseases","volume":"9","author":"Wasserman","year":"2017","journal-title":"Immunotherapy"},{"issue":"7","key":"10.1016\/j.ejpb.2024.114474_b0285","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.xphs.2021.03.017","article-title":"A review of formulations of commercially available antibodies","volume":"110","author":"Strickley","year":"2021","journal-title":"J Pharm Sci-Us"},{"key":"10.1016\/j.ejpb.2024.114474_b0290","unstructured":"United States Food and Drug Administration. Drugs@FDA: FDA-Approved Drugs. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=BasicSearch.process."},{"issue":"9","key":"10.1016\/j.ejpb.2024.114474_b0295","first-page":"1053","article-title":"Reversing Facial fillers: interactions between hyaluronidase and commercially available hyaluronic-acid based fillers","volume":"13","author":"Rao","year":"2014","journal-title":"J. Drugs Dermatol."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114474_b0300","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1080\/10717544.2018.1551442","article-title":"ENHANZE\u00ae drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20 (vol 26, pg 98, 2019)","volume":"26","author":"Locke","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114474_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2020.100604","article-title":"A phase I study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of recombinant human hyaluronidase PH20 administered intravenously in healthy volunteers","volume":"93","author":"Printz","year":"2020","journal-title":"Curr Ther Res Clin E"},{"issue":"6","key":"10.1016\/j.ejpb.2024.114474_b0310","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s11523-019-00684-y","article-title":"Subcutaneous trastuzumab: a review in HER2-positive breast cancer","volume":"14","author":"Heo","year":"2019","journal-title":"Target. Oncol."},{"issue":"12","key":"10.1016\/j.ejpb.2024.114474_b0315","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.NAJ.0000803180.17463.0b","article-title":"Daratumumab plus hyaluronidase-fihj (Darzalex Faspro)","volume":"121","author":"Aschenbrenner","year":"2021","journal-title":"Am. J. Nurs."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114474_b0320","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1158\/1078-0432.CCR-20-3474","article-title":"FDA approval summary: pertuzumab, trastuzumab, and hyaluronidase-zzxf injection for subcutaneous use in patients with HER2-positive breast cancer","volume":"27","author":"Gao","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114474_b0325","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40265-022-01712-4","article-title":"Efgartigimod: first approval (vol 82, pg 341, 2022)","volume":"82","author":"Heo","year":"2022","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114474_b0330","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/acssensors.2c02602","article-title":"Sensing technologies for extravasation detection: a review","volume":"8","author":"Hirata","year":"2023","journal-title":"ACS Sensors"},{"key":"10.1016\/j.ejpb.2024.114474_b0335","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.ajem.2012.03.005","article-title":"Extravasation of contrast media managed with recombinant human hyaluronidase","volume":"30","author":"Rowlett","year":"2012","journal-title":"Am. J. Emerg. Med."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114474_b0340","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/phar.2794","article-title":"Management of noncytotoxic extravasation injuries: A focused update on medications, treatment strategies, and peripheral administration of vasopressors and hypertonic saline","volume":"43","author":"Stefanos","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejpb.2024.114474_b0345","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s12887-022-03511-y","article-title":"A new approach to skin extravasation injury management during the neonatal period","volume":"22, (1)","author":"Sagheb","year":"2022","journal-title":"BMC Pediatr."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114474_b0350","doi-asserted-by":"crossref","first-page":"993","DOI":"10.36849\/JDD.2020.5416","article-title":"Hyaluronidase in dermatology: uses beyond hyaluronic acid fillers","volume":"19","author":"Searle","year":"2020","journal-title":"J. Drugs Dermatol."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114474_b0355","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.bjps.2021.03.125","article-title":"Use of hyaluronidase in plastic surgery: a review","volume":"74","author":"Sharma","year":"2021","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114474_b0360","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJMcibr2107204","article-title":"To scar or not to scar","volume":"385","author":"Clark","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2024.114474_b0365","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jconrel.2022.01.043","article-title":"Fully armed photodynamic therapy with spear and shear for topical deep hypertrophic scar treatment","volume":"343","author":"Huang","year":"2022","journal-title":"J. Control. Release"},{"issue":"Jan27","key":"10.1016\/j.ejpb.2024.114474_b0370","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(51)93361-2","article-title":"Procaine with hyaluronidase as local anaesthetic","volume":"260","author":"Thorpe","year":"1951","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejpb.2024.114474_b0375","doi-asserted-by":"crossref","first-page":"771e","DOI":"10.1097\/PRS.0b013e318245ea27","article-title":"Efficacy study of hyaluronidase as a diffusion promoter for lidocaine in infiltration analgesia of skin","volume":"129","author":"Wohlrab","year":"2012","journal-title":"Plast. Reconstr. Surg."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114474_b0380","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/imj.13574","article-title":"Recent advances in malignant melanoma","volume":"47","author":"Atkinson","year":"2017","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.ejpb.2024.114474_b0385","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jconrel.2022.06.021","article-title":"Research progress of microneedles in the treatment of melanoma","volume":"348","author":"Li","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114474_b0390","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.actbio.2022.05.015","article-title":"Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment","volume":"147","author":"Huang","year":"2022","journal-title":"Acta Biomater."},{"issue":"11","key":"10.1016\/j.ejpb.2024.114474_b0395","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1021\/acs.nanolett.2c01332","article-title":"Framework nucleic acid immune adjuvant for transdermal delivery based chemo-immunotherapy for malignant melanoma treatment","volume":"22","author":"Shen","year":"2022","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114474_b0400","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1089\/hum.2011.073","article-title":"Hyaluronidase and collagenase increase the transfection efficiency of gene electrotransfer in various murine tumors","volume":"23","author":"Cemazar","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ejpb.2024.114474_b0405","doi-asserted-by":"crossref","first-page":"14913","DOI":"10.1038\/s41598-018-33337-7","article-title":"Hyaluronic acid-CD44 interactions promote BMP4\/7-dependent Id1\/3 expression in melanoma cells","volume":"8","author":"Wu","year":"2018","journal-title":"Sci Rep-Uk"},{"issue":"6","key":"10.1016\/j.ejpb.2024.114474_b0410","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/ijd.15811","article-title":"Localized scleroderma: actual insights and new biomarkers","volume":"61","author":"Snarskaya","year":"2021","journal-title":"Int. J. Dermatol."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114474_b0415","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clindermatol.2018.04.005","article-title":"Morphea: current concepts","volume":"36","author":"Florez-Pollack","year":"2018","journal-title":"Clin. Dermatol."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114474_b0420","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jdcr.2019.08.004","article-title":"Hyaluronidase injections for treatment of symptomatic pansclerotic morphea-induced microstomia","volume":"5","author":"Abbas","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"7","key":"10.1016\/j.ejpb.2024.114474_b0425","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/jamadermatol.2019.0585","article-title":"Hyaluronidase treatment of scleroderma-induced microstomia","volume":"155","author":"Melvin","year":"2019","journal-title":"JAMA Dermatol."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114474_b0430","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00266-019-01421-6","article-title":"Reversal of post-filler vision loss and skin ischaemia with high-dose pulsed hyaluronidase injections","volume":"43","author":"Wibowo","year":"2019","journal-title":"Aesthetic Plast. Surg."},{"key":"10.1016\/j.ejpb.2024.114474_b0435","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/940615","article-title":"Treatment of ganglion cysts","volume":"2013","author":"Suen","year":"2013","journal-title":"ISRN Orthop"},{"issue":"6","key":"10.1016\/j.ejpb.2024.114474_b0440","first-page":"E61","article-title":"This month's guideline: the use of hyaluronidase in aesthetic practice (v2.4)","volume":"11","author":"King","year":"2018","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.ejpb.2024.114474_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122122","article-title":"Gold nanoparticles for skin drug delivery","volume":"625","author":"Chen","year":"2022","journal-title":"Int J Pharmaceut"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114474_b0450","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114474_b0455","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/10408398.2022.2105800","article-title":"Polysaccharide-based nano-delivery systems for encapsulation, delivery, and pH-responsive release of bioactive ingredients","volume":"64","author":"Meng","year":"2024","journal-title":"Crit Rev Food Sci"},{"key":"10.1016\/j.ejpb.2024.114474_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123976","article-title":"Multifunctionality of cyclodextrin-based polymeric nanoparticulate delivery systems for chemotherapeutics, combination therapy, and theranostics","volume":"654","author":"Devi","year":"2024","journal-title":"Int J Pharmaceut"},{"issue":"7","key":"10.1016\/j.ejpb.2024.114474_b0465","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1021\/acs.molpharmaceut.0c00294","article-title":"Hyaluronidase coated molecular envelope technology nanoparticles enhance drug absorption via the subcutaneous route","volume":"17","author":"Soundararajan","year":"2020","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114474_b0470","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1021\/acs.nanolett.6b00820","article-title":"Hyaluronidase embedded in nanocarrier PEG shell for enhanced tumor penetration and highly efficient antitumor efficacy","volume":"16","author":"Zhou","year":"2016","journal-title":"Nano Lett."},{"issue":"20","key":"10.1016\/j.ejpb.2024.114474_b0475","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.1039\/c3nr02787b","article-title":"Hyaluronan degrading silica nanoparticles for skin cancer therapy","volume":"5","author":"Scodeller","year":"2013","journal-title":"Nanoscale"},{"issue":"16","key":"10.1016\/j.ejpb.2024.114474_b0480","doi-asserted-by":"crossref","first-page":"18273","DOI":"10.1021\/acsami.0c00355","article-title":"Reduction\/oxidation-responsive hierarchical nanoparticles with self-driven degradability for enhanced tumor penetration and precise chemotherapy","volume":"12","author":"Yin","year":"2020","journal-title":"Acs Appl Mater Inter"},{"key":"10.1016\/j.ejpb.2024.114474_b0485","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biomaterials.2018.04.039","article-title":"Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase","volume":"171","author":"Guan","year":"2018","journal-title":"Biomaterials"},{"issue":"23","key":"10.1016\/j.ejpb.2024.114474_b0490","doi-asserted-by":"crossref","first-page":"26790","DOI":"10.1021\/acsami.1c06725","article-title":"Hyalase-mediated cascade degradation of a matrix barrier and immune cell penetration by a photothermal microneedle for efficient anticancer therapy","volume":"13","author":"He","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"10","key":"10.1016\/j.ejpb.2024.114474_b0495","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.drudis.2021.07.010","article-title":"Pharmaceutical nanocrystals: a promising approach for improved topical drug delivery","volume":"26","author":"Parmar","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2024.114474_b0500","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/pharmaceutics15030788","article-title":"Hyaluronidase promote transdermal diffusion of small sized curcumin nanocrystal by dissolving microneedles delivery","volume":"15, (3)","author":"Miao","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114474_b0505","doi-asserted-by":"crossref","unstructured":"N. Kasinathan, S.M. Volety, V.R. Josyula, Application of experimental design in preparation of nanoliposomes containing hyaluronidase, J. Drug De. 2014 (2014) 1\u20137.","DOI":"10.1155\/2014\/948650"},{"key":"10.1016\/j.ejpb.2024.114474_b0510","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jconrel.2022.11.007","article-title":"Extracellular matrix degrading enzyme with stroma-targeting peptides enhance the penetration of liposomes into tumors","volume":"352","author":"Ikeda-Imafuku","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114474_b0515","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2022.09.025","article-title":"Overcoming skin barriers through advanced transdermal drug delivery approaches","volume":"351","author":"Phatale","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114474_b0520","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.urology.2016.07.007","article-title":"Ultrastructural analysis of the foreskin in patients with true phimosis treated or not treated with topical betamethasone and hyaluronidase ointment","volume":"98","author":"Favorito","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.ejpb.2024.114474_b0525","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.colsurfb.2019.04.028","article-title":"Facile fabrication of PEG-coated PLGA microspheres via SPG membrane emulsification for the treatment of scleroderma by ECM degrading enzymes","volume":"179","author":"Ohta","year":"2019","journal-title":"Colloid Surface B"},{"key":"10.1016\/j.ejpb.2024.114474_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2022.108018","article-title":"Insights into the source, mechanism and biotechnological applications of hyaluronidases","volume":"60","author":"Zhang","year":"2022","journal-title":"Biotechnol. Adv."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114474_b0535","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/asj\/sjx221","article-title":"Commentary on: efficacy of retrobulbar hyaluronidase injection for vision loss resulting from hyaluronic acid filler embolization","volume":"38","author":"DeLorenzi","year":"2018","journal-title":"Aesthet. Surg. J."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114474_b0540","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/14764172.2017.1293825","article-title":"The duration of hyaluronidase and optimal timing of hyaluronic acid (HA) filler reinjection after hyaluronidase injection","volume":"20","author":"Kim","year":"2018","journal-title":"J. Cosmet. Laser Ther."},{"key":"10.1016\/j.ejpb.2024.114474_b0545","doi-asserted-by":"crossref","unstructured":"K. Fl\u00e9geau, J. Jing, R. Brusini, M. Gallet, C. Moreno, L. Walker, F. ourdon, J. Faivre, Multidose hyaluronidase administration as an optimal procedure to degrade resilient hyaluronic acid soft tissue fillers, Molecules 28(3) (2023) 1003.","DOI":"10.3390\/molecules28031003"},{"issue":"8","key":"10.1016\/j.ejpb.2024.114474_b0550","first-page":"E69","article-title":"Guideline for the Safe use of hyaluronidase in aesthetic medicine, including modified high-dose protocol","volume":"14","author":"Murray","year":"2021","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.ejpb.2024.114474_b0555","doi-asserted-by":"crossref","first-page":"e50403","DOI":"10.2196\/50403","article-title":"Hyaluronidase for dermal filler complications: review of applications and dosage recommendations","volume":"7","author":"Kroumpouzos","year":"2024","journal-title":"JMIR Dermatol"},{"issue":"4","key":"10.1016\/j.ejpb.2024.114474_b0560","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.matbio.2009.12.007","article-title":"pH effects on the hyaluronan hydrolysis catalysed by hyaluronidase in the presence of proteins: Part I. Dual aspect of the pH-dependence","volume":"29","author":"Lenormand","year":"2010","journal-title":"Matrix Biol."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114474_b0565","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/DSS.0000000000001084","article-title":"The kinetics of reversible hyaluronic acid filler injection treated with hyaluronidase","volume":"43","author":"Juh\u00e1sz","year":"2017","journal-title":"Dermatol. Surg."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114474_b0570","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00266-022-03207-9","article-title":"A scoping review of hyaluronidase use in managing the complications of aesthetic interventions","volume":"48","author":"Borzabadi-Farahani","year":"2024","journal-title":"Aesthet. Plast. Surg."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112400300X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112400300X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T01:20:47Z","timestamp":1730078447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964112400300X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":114,"alternative-id":["S093964112400300X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114474","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyaluronidase overcomes the extracellular matrix barrier to enhance local drug delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114474"}}